Repare Therapeutics Inc (RPTX) — Capital Reinvestment Ratio
Repare Therapeutics Inc (RPTX) has a Capital Reinvestment Ratio of 0.00x as of September 2022, meaning it reinvests 0% of its operating cash flow ($88.16 Million) in capital expenditures ($266.00K). Check Repare Therapeutics Inc tangible equity quality to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Repare Therapeutics Inc Capital Reinvestment Ratio (2022–2022)
This chart tracks Repare Therapeutics Inc's Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see Repare Therapeutics Inc (RPTX) cash conversion ratio.
Annual Capital Reinvestment Ratio for Repare Therapeutics Inc (2022–2022)
Year-by-year Capital Reinvestment Ratio for Repare Therapeutics Inc from 2022 to 2022. See RPTX cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 1.87x | $322.00K | $602.00K | — |